✦ LIBER ✦

Phase II Trial of Neoadjuvant Exemestane in Combination With Celecoxib in Postmenopausal Women Who Have Breast Cancer

✍ Scribed by Maryam B. Lustberg; Stephen P. Povoski; Weiqiang Zhao; Rebecca M. Ziegler; Yasuro Sugimoto; Amy S. Ruppert; Amy M. Lehman; Donna R. Shiels; Ewa Mrozek; Bhuvaneswari Ramaswamy; Rachel M. Layman; Robert W. Brueggemeier; Charles L. Shapiro

Book ID: 113538923
Publisher: CIG Media Group, LP.
Year: 2011
Tongue: English
Weight: 509 KB
Volume: 11
Category: Article
ISSN: 1526-8209
DOI: 10.1016/j.clbc.2011.03.022

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase II Trial of Exemestane in Combinat

Phase II Trial of Exemestane in Combination With Fulvestrant in Postmenopausal Women With Advanced, Hormone-Responsive Breast Cancer

✍ Ewa Mrózek; Rachel Layman; Bhuvaneswari Ramaswamy; Larry Schaaf; Xiaobai Li; Sus 📂 Article 📅 2012 🏛 CIG Media Group, LP. 🌐 English ⚖ 354 KB

Exemestane as primary treatment of oestr

Exemestane as primary treatment of oestrogen receptor-positive breast cancer in postmenopausal women: a phase II trial

✍ Barnadas, A; Gil, M; González, S; Tusquets, I; Muñoz, M; Arcusa, A; Prieto, L; M 📂 Article 📅 2009 🏛 Nature Publishing Group 🌐 English ⚖ 178 KB

Multicenter phase II trial of neoadjuvan

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone-sensitive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)

✍ H. Takei; Suemasu; K. Inoue; T. Saito; K. Okubo; J. Koh; K. Sato; H. Tsuda; M. K 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 270 KB

Everolimus in Combination with Exemestan

Everolimus in Combination with Exemestane for Postmenopausal Women with Advanced Breast Cancer Who Are Refractory to Letrozole or Anastrozole: Results of the BOLERO-2 Phase III Trial

✍ J. Baselqa; M. Campone; T. Sahmoud; M. Piccart; H. Burris; H. Rugo; S. Noguchi; 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 69 KB

Multicenter phase II trial of neoadjuvan

Multicenter phase II trial of neoadjuvant exemestane for postmenopausal patients with hormone receptor-positive, operable breast cancer: Saitama Breast Cancer Clinical Study Group (SBCCSG-03)

✍ Hiroyuki Takei; Kimito Suemasu; Kenichi Inoue; Tsuyoshi Saito; Katsuhiko Okubo; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 228 KB

Pharmacokinetics and tolerability of exe

Pharmacokinetics and tolerability of exemestane in combination with raloxifene in postmenopausal women with a history of breast cancer

✍ T. A. Traina; I. Poggesi; M. Robson; A. Asnis; B. A. Duncan; A. Heerdt; C. Dang; 📂 Article 📅 2007 🏛 Springer US 🌐 English ⚖ 417 KB